TrialJAMA ophthalmology2022

Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial.

George O Waring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.